Glycated hemoglobin follow-up of sis-hiperdia (Muriaé-Minas Gerais, Brazil)

Background The glycated hemoglobin (HbA1C) test, essential for diabetic patients follow-up, measures the concentrations of glycated hemoglobin in the blood, which can indicate, as they increase in proportion to glucose rates, the possibility of complications of the disease. Furthermore, the test points to the risk of Type 2 diabetes mellitus (T2D) development, for concentration values between 5.7% and 6.4%, and confirms its diagnosis if values exceed 6.5% in two different tests. In T2D patients, values above 7% imply heightened risk of microvascular complications and neuropathy. Several factors in the patients’ lifestyle affect these values, such as the practice of physical activities, diet and weight control.